Theriva Biologics, Inc. (TOVX)
0.3073
+0.06
(+26.20%)
USD |
NYAM |
Jun 11, 11:35
Theriva Biologics 1 Year Total Returns (Daily) : -50.81% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | -50.81% |
| June 09, 2026 | -49.19% |
| June 08, 2026 | -44.89% |
| June 05, 2026 | -45.82% |
| June 04, 2026 | -38.32% |
| June 03, 2026 | -38.72% |
| June 02, 2026 | -41.47% |
| June 01, 2026 | -39.60% |
| May 29, 2026 | -37.21% |
| May 28, 2026 | -27.82% |
| May 27, 2026 | -31.56% |
| May 26, 2026 | -34.73% |
| May 22, 2026 | -32.28% |
| May 21, 2026 | -35.52% |
| May 20, 2026 | -31.22% |
| May 19, 2026 | -49.16% |
| May 18, 2026 | -47.19% |
| May 15, 2026 | -46.22% |
| May 14, 2026 | -43.41% |
| May 13, 2026 | -41.07% |
| May 12, 2026 | -37.80% |
| May 11, 2026 | -35.65% |
| May 08, 2026 | -44.96% |
| May 07, 2026 | -55.56% |
| May 06, 2026 | -71.91% |
| Date | Value |
|---|---|
| May 05, 2026 | -72.75% |
| May 04, 2026 | -72.49% |
| May 01, 2026 | -72.17% |
| April 30, 2026 | -73.44% |
| April 29, 2026 | -76.67% |
| April 28, 2026 | -74.65% |
| April 27, 2026 | -75.11% |
| April 24, 2026 | -73.04% |
| April 23, 2026 | -73.36% |
| April 22, 2026 | -73.33% |
| April 21, 2026 | -74.14% |
| April 20, 2026 | -69.75% |
| April 17, 2026 | -81.02% |
| April 16, 2026 | -80.89% |
| April 15, 2026 | -81.43% |
| April 14, 2026 | -83.38% |
| April 13, 2026 | -77.80% |
| April 10, 2026 | -80.28% |
| April 09, 2026 | -75.50% |
| April 08, 2026 | -71.98% |
| April 07, 2026 | -76.24% |
| April 06, 2026 | -76.99% |
| April 02, 2026 | -80.52% |
| April 01, 2026 | -79.77% |
| March 31, 2026 | -82.20% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -4.28% |
| Alnylam Pharmaceuticals, Inc. | -3.72% |
| Savara, Inc. | 118.5% |
| Vericel Corp. | -18.21% |
| Biogen, Inc. | 43.36% |